
Canaccord Genuity Sticks to Their Buy Rating for Impedimed Limited (IPDQF)

I'm PortAI, I can summarize articles.
Storey covers the Healthcare sector, focusing on stocks such as Somnomed Limited, Impedimed Limited, and CSL. According to TipRanks, Storey has an average return of 9.0% and a 52.36% success rate on recommended stocks. Currently, the analyst consensus on Impedimed Limited is a Strong Buy with an average price target of $0.07.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

